# Corteva

**Source:** https://geo.sig.ai/brands/corteva  
**Vertical:** Manufacturing  
**Subcategory:** Enterprise  
**Tier:** Leader  
**Website:** corteva.com  
**Last Updated:** 2026-04-14

## Summary

Indianapolis agricultural seeds and crop protection (NYSE: CTVA) $17.2B FY2024 revenue; Pioneer Hi-Bred seeds, Enlist weed system, Qrome corn traits, competing with Bayer Crop Science and Syngenta.

## Company Overview

Corteva, Inc. is an Indianapolis, Indiana-based agricultural science company — publicly traded on the New York Stock Exchange (NYSE: CTVA) as an S&P 500 Materials component — developing and selling seeds (Pioneer brand corn, soybean, sunflower, and vegetable seeds) and crop protection products (herbicides, insecticides, fungicides under Enlist, Instinct, Zorvec, and other brands) to farmers across 140 countries through approximately 22,000 employees. Corteva was spun off from DowDuPont in June 2019 as the agricultural science component of the DowDuPont three-way breakup (materials science → Dow Inc., specialty products → DuPont de Nemours, agriculture → Corteva), combining the Pioneer Hi-Bred seed genetics legacy (acquired by DuPont in 1999 for $9.4 billion) with the Dow AgroSciences crop protection portfolio. In fiscal year 2024, Corteva reported revenues of $17.2 billion, with the Seed segment (corn, soybean, and specialty crop seeds) generating $9.3 billion and the Crop Protection segment (pesticides, herbicides, fungicides) generating $7.9 billion — though crop protection faced market headwinds from generic agrochemical price competition and grower inventory destocking as global commodity crop prices fell from 2022-2023 peaks. CEO Chuck Magro's strategy focuses on driving pricing power through genetic trait performance (Corteva's Qrome corn trait technology delivering 5-10 bushel/acre yield advantage driving premium seed pricing) and the Enlist weed control system (herbicide-tolerant soybeans paired with Enlist Duo herbicide through a closed IP system that bundles herbicide and trait royalty revenue).

Corteva's agricultural seeds and crop protection model creates competitive advantages through the proprietary germplasm library and trait technology that took decades to develop: Pioneer Hi-Bred's 100+ years of corn breeding research (founded 1926, acquired by DuPont 1999) produced a genetic diversity library of 50,000+ corn inbreds evaluated in thousands of growing environments annually — a germplasm asset that Corteva's competitors (Bayer Crop Science / Monsanto, Syngenta) could not replicate without 50+ years of parallel breeding investment. The trait licensing architecture (Pioneer seeds engineered with Corteva's proprietary Qrome, PowerCore, and Herculex traits plus licensed Monsanto/Bayer traits where needed) creates royalty structures where premium corn hybrids generate $300-500/bag seed pricing versus $100-150/bag for commodity seeds without premium traits. The Enlist system (Enlist E3 soybean seeds + Enlist Duo 2,4-D/glufosinate herbicide) creates a closed weed management system that captures both seed and herbicide revenue from farmers who adopt the weed control system.

In 2025, Corteva competes in agricultural seeds and crop protection against Bayer Crop Science (ETR: BAYN, $11B agroscience division, Roundup Ready soybean traits and Dekalb corn seeds), Syngenta Group (private, ChemChina subsidiary, $28B+ revenue, NK Seeds and Amistar fungicides), and FMC Corporation (NYSE: FMC, $4.5B revenue, specialty crop protection insecticides and herbicides) for US corn and soybean seed market share, crop protection product sales through dealer networks, and biological crop protection product adoption. The crop protection pricing headwinds (generic manufacturers from China and India producing off-patent agrochemicals at 50-60% discount to branded crop protection products) have compressed Corteva's crop protection margins — driving investment in novel molecules (Isoclast insecticide, Zorvec fungicide) and biological products (Utrisha N nitrogen fixation inoculant) with 10-15 year IP protection. The seed business pricing power (Pioneer corn hybrids earning $20-40/bag annual price increases through proven trait performance) provides margin resilience even as crop protection pricing faces generic competition. The 2025 strategy focuses on Enlist adoption expansion in US soybeans, novel molecule crop protection volume growth in Latin America, and biological product portfolio commercialization that diversifies beyond synthetic chemistry.

## Frequently Asked Questions

### What does Corteva do?
Corteva Agriscience is a global leader in agricultural science providing advanced seed genetics, crop protection products, and digital agriculture technologies to farmers in over 110 countries. The company operates through two main segments: Seeds (including Pioneer and Brevant brands) offering high-performance corn, soybean, and specialty crop genetics, and Crop Protection providing fungicides, herbicides, insecticides, and biologicals. With approximately $17 billion in annual revenue and 22,000 employees, Corteva helps farmers sustainably produce food while investing nearly $4 million daily in R&D to develop breakthrough agricultural innovations.

### Who are Corteva's customers and target market?
Corteva serves farmers and agricultural producers across major crop markets globally, with presence in over 110 countries. Primary customers include commercial farmers growing corn, soybeans, wheat, and other major crops who need high-performance seeds, crop protection solutions, and agricultural technologies. The company serves customers through multiple go-to-market channels including direct sales, retail partnerships, and regional seed brands (Pioneer, Brevant, Dairyland, NuTech, Seed Consultants, Terral), enabling tailored solutions for diverse geographic markets and farming operations from small family farms to large commercial agricultural enterprises.

### When was Corteva founded?
Corteva Agriscience was formally established in March 2018 as a subsidiary of DowDuPont and became an independent public company on June 1, 2019, through a corporate spin-off. The company combines the agricultural heritages of DuPont Pioneer (founded in 1926) and Dow AgroSciences, bringing together over 90 years of seed innovation and decades of crop protection expertise. James C. Collins Jr. served as the inaugural CEO, with Chuck Magro becoming CEO in 2021.

### Where is Corteva headquartered?
Corteva's global headquarters is located in Indianapolis, Indiana, following a 2022 relocation from Wilmington, Delaware. The move brought the company closer to agricultural operations, technology centers, and customers in the agricultural heartland. Corteva maintains a significant office presence in downtown Wilmington for key corporate and business functions supporting over 200 employees, and operates research facilities, production sites, and commercial offices across 110+ countries worldwide.

### How much funding has Corteva raised?
Corteva was created through the 2017 Dow-DuPont merger and spun off as an independent public company in June 2019, rather than through traditional venture capital funding. As a publicly traded company on NYSE (CTVA) since its spin-off, Corteva has not raised external funding. The company generates strong free cash flow ($1.7 billion in FY 2024, up 40% year-over-year) which funds operations, R&D investment of approximately 8% of revenue, strategic acquisitions, and shareholder returns of roughly $4.5 billion planned through 2027.

### What makes Corteva different from competitors?
Corteva differentiates through its balanced portfolio combining both seed and crop protection capabilities in a single integrated platform, unlike some competitors focused on single segments. The company's Pioneer brand represents the world's leading seed franchise with unmatched germplasm diversity and breeding expertise developed over 90+ years. Corteva invests approximately 8% of revenue ($4 million daily) in R&D, maintaining one of the industry's strongest innovation pipelines spanning gene editing, biologicals, and digital agriculture. The company's six growth platforms (seed/trait licensing, biologicals, new crop protection technologies, gene editing, biofuels, hybrid wheat) position it for diversified long-term growth, supported by the planned 2026 separation into two focused companies.

### Who are Corteva's main competitors?
Corteva's main competitors in agricultural sciences include Bayer Crop Science, Syngenta Group (ChemChina), BASF Agricultural Solutions, FMC Corporation, and Nutrien. Bayer and Corteva together provide over half of U.S. retail seed sales for corn, soybeans, and cotton. In crop protection, the industry is dominated by four major firms: Bayer, Corteva, Syngenta, and BASF, which control the majority of global agricultural chemical sales. Corteva's integrated seed and crop protection model differentiates it from specialized competitors, though the company's planned 2026 separation will create two focused entities competing in distinct market segments.

### How can I contact Corteva?
You can contact Corteva through their website at www.corteva.com or reach their Indianapolis headquarters. For investor relations inquiries, visit investors.corteva.com. The company maintains regional sales and technical support teams across 110+ countries to serve farmers and agricultural customers. Corteva's commercial organization operates through established distribution channels including retail partners and direct sales teams who provide localized support and agronomic expertise.

### Is Corteva hiring?
Yes, Corteva actively recruits talent across its 22,000-employee global workforce. The company offers career opportunities in agricultural research, biotechnology, field sales, agronomy, manufacturing, and corporate functions across 110+ countries. Corteva is committed to diversity and inclusion with goals to empower women, enable youth, and achieve one million volunteer employee hours by 2030. The company provides opportunities to work at cutting-edge research facilities, including Centers for Seed Applied Technologies and breeding stations, contributing to innovations that help sustainably feed the world.

### What's the latest news about Corteva?
Major recent developments include the October 2025 announcement that Corteva will separate into two independent public companies by late 2026—one focused on crop protection and biologicals, the other on advanced genetics and emerging technologies. In 2024, Corteva unveiled a financial framework through 2027 targeting $1 billion in incremental sales from growth platforms and approximately $1 billion in productivity benefits. The company achieved strong Q3 2025 results with raised full-year guidance and continues expanding its biologicals business (targeting $1 billion in annual revenue) through strategic acquisitions like Stoller Group and Symborg.

### What is Corteva's market position?
Corteva is an S&P 500 component company with annual revenues of approximately $16.9-17 billion, making it one of the world's largest pure-play agricultural companies. The company holds leading positions in both seeds (Pioneer is the #1 seed brand globally) and crop protection (top 4 globally). Corteva and Bayer together account for over 50% of U.S. corn, soybean, and cotton seed sales. The company generated operating EBITDA of $3.4 billion in 2024 with free cash flow of $1.7 billion, demonstrating strong financial performance and market position in serving farmers across 110+ countries.

### What are Corteva's future plans?
Corteva's strategic priorities include executing the planned separation into two independent companies by late 2026, launching 20 new products with $200+ million revenue potential during 2024-2025, scaling biologicals to $1 billion in annual revenue, and advancing six growth platforms (seed/trait licensing, biologicals, new crop protection, gene editing, biofuels, hybrid wheat). The company targets $17.2-17.6 billion in net sales for 2025 and has committed to 2030 sustainability goals including 65% emissions intensity reduction, supporting regenerative agriculture on 25 million acres, and 100% of new solutions meeting sustainability criteria. R&D investment remains at approximately 8% of revenue to maintain innovation leadership.

## Tags

b2b, manufacturing, agriculture, public, global, enterprise

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*